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al., 1989). In the same experimental system, peritoneal
B1 B cells were shown to generate strong primary
plasma cell responses (Linton et al., 1992). Similarly, it
was shown that antibodies arising early in the immune
response to influenza virus originate in the B1 subset,
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Birmingham, Alabama 35294 while high-affinity antibodies generated later were de-
rived from long-lived recirculating B2 B cells (Baumgarth
et al., 1999).
Recently, we showed that the ability of splenic MZ-Summary
enriched IgMhighCD21high B cells to generate plasma cells
after polyclonal in vitro stimulation is much higher thanThe rate of pathogen elimination determines the extent
and consequences of an infection. In this context, the that of the IgMlowCD21int recirculating FO B cells (Oliver
et al., 1999). In addition, similar to the B1 repertoire,spleen with its highly specialized lymphoid compart-
ments plays a central role in clearing blood-borne certain clones are enriched in the MZ repertoire by a
CD19 and btk tyrosine kinase-dependent mechanism ofpathogens. Splenic marginal zone B cells (MZ), by vir-
tue of their preactivated state and topographical loca- positive selection (Martin and Kearney, 2000a). Although
specialized cells in the splenic MZ have been shown totion, join B1 B cells to generate a massive wave of
IgM producing plasmablasts in the initial 3 days of capture and concentrate T-independent and particulate
antigens circulating in the blood, a direct contributiona primary response to particulate bacterial antigens.
Because of the intensity and rapidity of this response, of MZ-resident B cells to T-independent antibody re-
sponses has been difficult to demonstrate (Humphreycombined with the types of antibodies produced,
splenic MZ and B1 B cells endowed with a “natural and Grennan, 1981; Gray et al., 1985; Buiting et al., 1996).
Recently, pyk-2-deficient mice were shown to have amemory” provide a bridge between the very early in-
nate and the later appearing adaptive immune re- specific defect in MZ B cell development that was asso-
ciated with reduced T-independent (TI) antibody re-sponse.
sponses (Guinamard et al., 2000). However, the antibody
response was not abolished and the B cell response toIntroduction
the hapten TNP, which by nature is highly polyclonal,
did not permit a temporal or topographical tracing of theMature B cells upon activation perform a variety of ef-
fector functions, including antigen presentation and the histological events ensuing after antigenic challenge.
Here, we show directly that CD21high B lymphocytesgeneration of plasma cells and memory cells. In naive,
unimmunized animals, B cell heterogeneity exists with enriched in the MZ generate an early, exuberant plas-
mablast response after in vivo stimulation with a T-inde-respect to localization in anatomical environments (B1
cells) and positioning within the same organ as exempli- pendent antigen. In addition, we show that antigen-spe-
cific MZ B cell clones and normally dominant B1 B cellfied by the follicles (FO) and marginal zones (MZ) of the
spleen (Stall et al., 1996; Kraal, 1992). The mature B cell clones respond to a TI antigen at a level dependent
on their respective frequencies in the repertoire. Thesesubsets occupying these compartments exhibit differ-
ential phenotypes and functions (Hayakawa et al., 1997; results extend our understanding of the “division of la-
bor” found within the B cell repertoire where B cells withMond et al., 1995).
In T-dependent immune responses, primary foci of appropriate clonal specificities are selected into certain
B cell subsets (MZ and B1) and are deployed to giveactivated antigen-specific B cells that appear at the T-B
border 2 days after immunization give rise to both germi- rise to a rapid T-independent IgM antibody response.
nal center B cells in the secondary follicles and plasma
cells in the bridging channels and red pulp (Jacob et Results
al., 1991; Liu et al., 1992). In studies of T-independent
immune responses to soluble antigens in rats and mice, MZ B Cells Are Capable of Rapid Polyclonal
it has been shown that plasma cell formation in the TI Plasmablast Generation
bridging channels and red pulp follows a generalized B Our previous studies of splenic subsets showed that
cell proliferation in all splenic compartments (Liu et al., MZ B cells generate effector cells after polyclonal in
1991; de Vinuesa et al., 1999a). vitro stimulation much more efficiently than FO recircu-
Although mature long-lived B cells after antigen en- lating B cells (Oliver et al., 1999). As seen in Figure 1A,
counter give rise to plasmablasts and plasma cells, after 24 hr of stimulation by LPS in vitro a third of the
it is not known if these precursors are heterogeneous FACS-sorted MZ B cells express the plasma cell marker
with respect to phenotype and topographical location. Syndecan-1 (Syn1) on their surface, while only a small
Splenic CD24high B cells were shown to contain precur- proportion of FO B cells express this molecule. This
sors for primary antibody responses, while CD24low B difference in B cell maturation correlates with higher ex-
cells generated potent secondary responses (Linton et pression of the plasma cell transcription factor Blimp-1
(Messika et al., 1998) in freshly sorted MZ compared to
FO B cells and is further upregulated after in vitro LPS1 Correspondence: john.kearney@ccc.uab.edu
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Figure 1. CD23loCD21hi MZ B Cells Rapidly Generate Polyclonal Plasma Cells Both In Vitro and In Vivo
(A and B) Mature splenic B cells from 81x or BALB/c mice were sorted based on CD23 and CD21 expression, cultured with 10 mg/ml LPS in
vitro for 24 hr, and (A) stained for Syndecan-1 surface expression or (B) assayed for Blimp-1 message by RT-PCR. One of five similar
experiments is shown.
(C) CD23loCD21hi B cells enriched in the MZ of the spleen contain a dominant clone in M167 transgenic mice. Spleen cells from M167 transgenic
mice were stained with CD23, CD21, and M167 idiotype. Histograms represent the level of M167 staining in the CD23loCD21hi and CD23hiCD21int
populations. Spleen sections are stained with anti-IgMa (green), anti-M167 (orange), and anti-MOMA-1 (blue). Profiles and sections are
representative of 20 mice.
(D) MZ-enriched B cell clones (Id1) blast early (24 hr) after in vivo LPS injection. M167 and 81x mice were injected i.v. with 20 mg LPS or with
PBS, and at 24 hr the size (FSC) of MZ Id1 and FO Id2 is displayed as histograms. Data are representative of three to five mice in each group.
stimulation (Figure 1B). FO B cells also upregulate B cell clone is generated and selected into the MZ of
the spleen and can subsequently be traced by anti-Blimp-1 expression but only later after 48–72 hr of LPS
stimulation (data not shown). idiotypic reagents (Martin and Kearney, 2000a). As seen
in Figure 1C, 20% of MZ B cells in M167 Tg mice consistsTo determine if MZ B cells behave similarly when
stimulated in vivo by LPS, we took advantage of two of the VH1-Vk24 clone (M167 Id1), while only 1% of
the FO cells express this idiotype. Twenty-four hoursimmunoglobulin (Ig) heavy chain transgenic (Tg) mice:
M167 (VH1 heavy chain derived from anti-phosphory- after i.v. injection of LPS, a large proportion of the MZ
Id1 but not of FO Id2 B cell clones generate blastscholine [PC] hybridoma M167) and 81x (heavy chain
derived from a neonatal B cell hybridoma) (Storb et al., (Figure 1D).
These characteristics coupled with the high resting1986; Martin et al., 1997). In both models, a dominant
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level of Blimp-1 show that MZ B cells are poised to B cells or immature plasmablasts (Figure 3A). A re-
sponse with very similar kinetics is seen when micedifferentiate into plasma cells in response to in vitro and
in vivo TI polyclonal stimulation more rapidly than their deficient in T cells are used as recipients (TCR ko), prov-
ing the T-independent nature of the early MZ B cellFO counterparts.
activation (Figure 3A).
These results show that Id1 PC-specific B cells withTI Antigen-Specific B Cells, Predominantly of the MZ
MZ phenotype are the progenitors of the early plasmaPhenotype, Rapidly Generate Plasmablasts
cell wave in the T-independent response against PC.after Immunization In Vivo
We used M167 Tg mice containing a large population
Antigen-Specific T-Independent Plasmablastsof M167 Id1, mostly CD21high, PC-specific cells enriched
Are Derived from MZ B Cellsin the MZ to analyze the response of antigen-specific MZ
To directly confirm that the large plasmablast populationB cells in vivo (Figure 1C; Martin and Kearney, 2000a).
seen after TI antigen immunization derive from antigen-M167 mice were injected i.v. with PC1 bacteria, PC2
specific MZ B cells, sorted MZ and FO M167 transgenicbacteria derived by growth in media with ethanolamine
cells were transferred into normal C57BL/6 mice thatinstead of choline, or PBS, and fed with BrdU. M167 Id1
were immunized 24 hr later. Only mice receiving MZ Bcells previously enriched in the MZ had vacated the
cells (IgMa) developed a large antigen-specific (M167white pulp by 3 days and generated large numbers of
Id1) plasmablast population 3 days after immunizationPC-specific plasmablasts in the bridging channels and
(Figure 3B). In immunized mice receiving FO B cells,red pulp. Although PC2 bacteria also induced plas-
some donor plasmablasts can be detected and rare Id1mablasts in the bridging channels and red pulp, they
cells are seen; however, they fail to generate the largewere M167 Id2 and did not bind PC. Most blasts were
response of the MZ B cells. The above experimentgenerated by cell proliferation induced by immunization
shows that at natural M167 Id1 composition (MZ 20%since they were BrdU positive (Figure 2A). The PC-anti-
Id1, FO 1%–2% Id1), MZ cells generate a large responsegen dependence of the MZ depletion is confirmed by
while FO do not. When equal numbers of Id1 FO andthe lack of responding M167 Id1 cells in the MZ B cells
Id1 MZ cells were transferred into C57BL/6 recipients,in PC1 but not in PC2 or PBS immunized mice (Figure
after immunization both populations generated plas-2B). However, in both PC1 and PC2 injected mice resid-
mablasts but there was still a 2- to 3-fold larger responseual MZ B cells show a slight increase in mean FSC and
in the Id1 MZ recipients over the Id1 FO recipients (Fig-a higher percentage of cells incorporating BrdU than
ures 3C and 3D). This ability might be due to an intrinsicFO cells (not shown). This suggests that in addition to
property of MZ cells to be more “activable” (directly orthe PC-specific effects, MZ B cells are targeted by other
through interaction with other cells), or could result frombacterial components either in an antigen-specific or a
a more efficient homing and survival in the MZ, or both.bystander manner.
Since in transferred but unimmunized control mice thereAfter immunization with PC1 bacteria, within 4 hr most
were comparable number of Id1 cells in both groupsM167 Id1 B cells move to the T-B cell border (Figure 2C).
(not shown), we favor the first alternative, although theAfter 24 hr, although large Id1 B cell blasts proliferate in
small number of cells in unimmunized mice makes thisall splenic compartments they are heavily enriched at
quantification very difficult. The 10- to 20-fold Id enrich-the T-B border, where at 48 hr massive accumulations
ment in the MZ versus FO coupled with a 2- to 5-foldof plasmablasts form and expand through bridging
higher ability to generate plasmablasts implies that atchannels into the red pulp.
most 1%–5% of plasmablasts will derive from Id1 FOTo show that this sequence of events is not an artifact
cells under physiological conditions.of the high number of antigen-specific B cells in Tg mice,
These experiments clearly show that in vivo PC-spe-we transferred small numbers of spleen cells from M167
cific B cells from the MZ subset constitute the majoritytransgenic mice into C57BL/6 mice (Figure 3A). 12–24
of the precursors for plasmablasts resulting from PC TIhr after transfer, at a time when recipient mice are immu-
antigen immunizations.nized, transferred M167 Id1 cells were enriched in the
MZ (46 6 8%), with some (30 6 6%) in the red pulp
and a minority in B cell follicles. Conversely, transferred MZ Join B1 Antigen-Specific B Cell Clones in TI
Responses against Blood-Borne Antigenssorted FO B cells were present largely in the FO (68 6
8%), with fewer in the red pulp (27 6 10%) and only Having established that the MZ repertoire contains B
cells that are major contributors to the early phase ofvery rare cells in the MZ. This suggests that transferred
cells follow the trend of CD21high B cell enrichment in the TI response to PC, we next analyzed the participation
of other clones and subsets of potential PC-reactivethe MZ, which has been seen to various extents in all
transgenic as well as normal mice. After similar immuni- cells in a full scale response in normal mice. It is well
established that the canonical T151 clone generated byzation, the kinetics of migration and plasma cell forma-
tion in the recipients were parallel to those in the M167 the association of VH1 and Vk22 heavy and light chains
is responsible for 50%–90% of the TI anti-PC responsetransgenic mice. At 24 hr after immunization, the trans-
ferred PC binding B cells had lower levels of surface induced by PC1 bacteria in both BALB/c and C57BL/6
mice (Claflin et al., 1974; Gearhart et al., 1977). TheseIgMa and M167 Id indicative of receptor engagement by
antigen. Subsequently, this population became large B cells reside within the B1 compartment and their onto-
genetic appearance, frequency, and functions haveplasmablasts which peaked at day 3–4 and then de-
clined over the next 2 weeks, when most of the remaining been described in detail (Sigal et al., 1975; Masmoudi
et al., 1990). There are also other PC-responsive clonesPC-specific cells were mature plasma cells rather then
Immunity
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Figure 2. Anti-Phosphorylcholine Plasmablasts Generated Early after Immunization with Antigen-Bearing Bacteria Are M167 Idiotype Positive
(A) M167 transgenic mice were injected i.v. with PBS, PC1, or PC2 S. pneumoniae, sacrificed 3 days later, and their responses in the spleen
followed by flow cytometry and fluorescence microscopy. Cells were stained for flow cytometry with antibodies against IgM, Syndecan-1,
M167 Id, and BrdU. Tissue sections were stained with anti-IgMa (green), anti-M167 (orange), and anti-MOMA-1 (blue). Profiles are representative
of five mice in each group.
(B) After immunization with PC1 but not PC2 bacteria, antigen-specific cells disappeared from the CD23loCD21hi (MZ) B cell population. Spleen
cells from the same mice as in (A) were stained with anti-CD23, anti-CD21, and anti-M167 and gated as in Figure 1.
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Figure 3. MZ-Enriched Phosphorylcholine-Specific Cells Are the Source of Most Plasmablasts after Immunization with PC1 Bacteria
(A) 2 3 106 MACS purified B220 positive spleen cells from M167 transgenic mice were transferred i.v. into C57BL/6 or T ko C57BL/6 mice.
The next day, recipients were immunized as above and mice were sacrificed at day 1, 3, and 7. In the transfer system, the immune response
peaks at 3 days, similar to that of immunized intact M167 transgenic mice. Note the downregulation of the B cell receptor on antigen-specific
cells. Tissue sections from the same mice were stained with antibodies against IgMb (green), M167 idiotype (red), and CD5 (blue). Note the
clusters of plasmablasts in the absence of T cells (blue) in the T ko recipients.
(B) CD23loCD21hi M1671 cells generate plasma cells 3 days after immunization in vivo. 1.5 3 106 CD23loCD21hi or CD23hiCD21int B cells were
sorted from M167 transgenic mice, transferred into C57BL/6 mice, and the recipients immunized with PC1 bacteria 1 day later. Spleens from
recipients sacrificed 3 days after immunization were used for flow cytometry and fluorescence microscopy. Splenocytes were stained with
antibodies against IgMa, idiotype (M167), and Syndecan-1, as well as propidium iodide to exclude dead cells. 500,000 propidium iodide
negative events were acquired and the IgMa transferred cells gated and their M167 and Syn profile displayed. Profiles are representative of
two experiments with three to five mice in each group. Tissue sections were treated as in (A).
(C and D) At equal numbers, MZ Id1 give rise to more plasmablasts compared with of FO Id1 cells. Equivalent numbers of M167 transgenic
CD23loCD21hi Id1 and CD23hiCD21int Id1 cells were transferred into C57BL/6 recipients that were subsequently immunized and analyzed at
day 3. Spleen cells were stained for IgMa, M167 (Id), and Syndecan-1, and the IgMa/Id profiles were displayed as dot plots with the histogram
inset representing the Syndecan-1 expression on the gated transferred derived Id1 cells. The absolute number of Id1 derived plasmablasts
(Id1 Syn1) in 106 splenocytes is represented for each group of recipients (n 5 4 in each group). ND 5 not determined.
including M167 (VH1 and Vk24) that account for a minor without T cells, the B1-derived T15 clone and the MZ-
derived M167 clone respond both in the early stages ofportion of the response in C57BL/6 but not in BALB/c
mice (Claflin, 1976). As seen in Figure 4A at 3 days after the response, with T15 being highly dominant (Figure
4A). After exhaustive magnetic enrichment and the usei.v. immunization with PC1 bacteria, in both BALB/c (BA)
and C57BL/6 (B6) mice as well as in TCR ko C57BL/6 of a panel of markers, we confirmed the model in Figure
4A and showed that the large majority of T15 cells in(T ko), T15 is the dominant responding population, while
M167 is detected histologically as a minor subset only unimmunized normal mice belong to the B1 compart-
ment both in the spleen and peritoneal cavity (Figurein B6 and T ko B6 mice. Thus, in C57BL/6 mice with or
(C) Early in the immune response to phosphorylcholine, antigen-specific B cells migrate from the marginal zone to the T-B border (4 hr),
followed by proliferation and generation of antigen-specific plasma cells (24–48 hr). Sections of spleens from M167 transgenic mice, immunized
with PC1 bacteria, were stained with anti-IgMa (green), anti-M167 (orange), and anti-CD41 anti-CD8 (blue).
Immunity
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Figure 4. T151 B1 Antigen-Specific B Cells Participate in the Response against a Blood-Borne TI Antigen
(A) BALB/c, C57BL/6, and T ko C57BL/6 mice generate anti-PC plasmablasts with a dominant T15 idiotype 3 days after immunization. Tissue
sections from immunized and control mice were stained with antibodies against MOMA-1 (blue), T15 (green), and M167 (red). Spleen cells
were stained for flow cytometry with PC, anti-Syn, and either anti-T15 or anti-M167 antibodies. Dead cells were excluded using PI. 500,000
PI negative cells are displayed for PC and Syn as two-color histograms. Antigen-specific plasmablasts (PC1Syn1) are quantified as absolute
numbers (in 500,000 living cells) and as percentages and gated for the T15 and M167 profiles (displayed as one-color histograms). The
percentages of idiotype in anti-PC response in the graph on the top right represent four to five mice of each strain (BALB/c T15: 816 14%,
M167: 1.3 6 0.4%; C57BL/6 T15: 70 6 16%, M167: 9.75 6 4.7%; T ko B6: T15: 73 6 9%, M167: 6 6 2.4%).
(B) Anti-PC T151 B cells express predominantly the B1 phenotype in both spleen (SPL) and peritoneal cavity (PEC). Spleen cells from 15–30
BALB/c mice were magnetically (MACS) enriched for PC binding, and the T151 cells detected within this population (9 6 4% over five
experiments) were phenotyped for the markers shown as one-color histograms. These SPL T151 cells are compared with a similar population
derived from the PEC (PEC T151) and as a control the SPL T152, mostly B2 B cells (CD191 PC2). 81x mko mice were used as negative controls
for the specificity of the magnetic enrichment.
4B). T15 cells were larger in size, higher for CD19, CD5, spleen) and by higher levels of CD43 and Mac-1 present
in the PEC. These observations are concordant withCD43 and lower for IgD and CD23. However, reproduc-
ible small differences between the SPL and PEC T15 differences found between SPL and PEC B1 cells and
suggest that there may be functional heterogeneitycompartments do exist as exemplified by a slight differ-
ence in CD21 profiles (suggesting that perhaps a small within the B1 compartment.
To investigate factors determining the B1/MZ (T15/subset of them might actually belong to the MZ in the
MZ B Cells’ In Vivo Function
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Figure 5. Participation of the M167 Clone in the Anti-PC Plasmablast Response Is Proportional to the Amount of MZ M167 Precursors
C57BL/6 mice were transferred i.v. with a total of 20 3 106 M167 transgenic and filler spleen cells containing increasing numbers of M167
PC-specific B cells (0, 100, 1000, 10,000, and 100,000). At day 1, recipients were immunized with PC1 bacteria i.v., and at day 4 they were
killed and analyzed. Spleen sections were stained as in Figure 4A. Histograms represent the T15 and M167 idiotypes in PC1Syn1 cells analyzed
as in 4A. Sections and profiles are representative of at least five mice in each group from two independent experiments. Data from all mice
are included in graphs as percentage of T15 and M167 idiotype in the anti-PC response (B) or as total number of PC-specific, T15, and M167
plasma cells (C).
M167) composition of the anti-PC response, we trans- partments will respond early in TI challenges if they
contain precursors with appropriate specificities.ferred increasing numbers of M167 B cells into normal
mice and subsequently immunized them. In the immu-
nized recipients, increasing the frequency of MZ-origi- MZ B Cells Are Activated Only by Antigens Reaching
nating responders caused the MZ-derived clones (M167) the Spleen via a Blood-Borne Route
to overwhelm the normally dominant T15 response, and We next wished to determine the effects of the dose and
together the two idiotypes account for 75%–95% of the route of antigen exposure on the relative contributions of
anti-PC response in all groups (Figures 5A and 5B). The these two B cell subsets to the early anti-PC response.
total number of anti-PC and M167 plasmablasts increases By administering high (108 bacteria) or low (107) doses
proportionally to the number of M167 transferred cells, of the antigen either i.v. or i.p, the role of MZ B cells
while the T15 plasma cells decrease particularly at high was assayed in TI responses initiated either locally in
doses of M167 B transferred cells (Figure 5C). the peritoneal cavity (PEC) or systemically when the
In the first wave of B cell defense, a blood-borne TI antigen is present in the blood.
antigen will therefore target antigen-specific clones from C57BL/6 mice injected with high doses (108) of bacte-
these two compartments, which will respond according ria generated a B1 (T15)-dominated splenic response,
to their absolute frequencies in the preimmune reper- which was larger after i.v. than i.p. immunization (Figures
6A and 6B). At this high dose, i.p. administered bacteriatoire. Our results also predict that both B1 and MZ com-
Immunity
624
Figure 6. MZ Repertoire Joins a TI Response Only When the Antigen Is Disseminated via the Blood
C57BL/6 mice nonmanipulated or transferred with 5000 MZ-derived PC-specific cells (corresponding to 1 million total spleen cells from M167
transgenic mice) were immunized, killed 3 days later, and analyzed as described in Figure 4. Immunization is either i.v. or i.p. and the dose
is either 108 or 107 PC1 bacteria. Spleen sections were treated as in Figure 4. Data from the graphs for the spleen and PEC response (B–E)
are derived from flow cytometric profiles similar to Figure 4.
MZ B Cells’ In Vivo Function
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phenotypes. In contrast, when antigen exposure is con-
fined to a localized environment (low dose i.p. injection),
the MZ cells do not participate and the response is
almost entirely B1 derived (Figure 7).
These results show that the dose and route of admin-
istration play an important role in the clearance of anti-
gen. By using different antigen doses given i.p., we at-
tempted to mimic a local infection (low dose) or a
hematogenic spreading (high dose). The B1 subset can
adequately clear locally encountered antigen, but as
soon as a systemic spread occurs, MZ B cells in the
spleen are enjoined rapidly into the response. These
experiments clearly establish that both MZ and B1 B cell
subsets are crucial compartments in the rapid response
against TI antigens. However, the spleen with its highly
efficient filtering and antigen-trapping mechanisms is
the ultimate backup and contributes maximally to the
clearance of blood-borne antigens.
Discussion
We have shown that in TI responses to particulate anti-
gens, CD21hiCD23lo B cells enriched in the splenic MZ
produce most of the early IgM producing plasma cell
wave that peaks at day 3–4 after antigen encounter. We
provide direct evidence that after antigenic stimulation
MZ B cells migrate from the MZ and differentiate rapidly
into plasmablasts.
Although the kinetics of responses to soluble TI anti-Figure 7. Scheme of Anti-PC TI Response Incorporating the Origin
of Responding Cells, the Antigenic Dose, and Route of Immunization gens were described previously, the source of re-
sponding cells and the early events involved in the mi-B1 (T15, green)- and MZ (M167, red)-derived clones participate in
the early (3 days) response against PC1 bacteria. When the antigen gration of the antigen-specific cells were not addressed
reaches the blood either by direct injection (107 and 108 i.v.) or (Liu et al., 1991; de Vinuesa et al., 1999a). In TI-specific
by dissemination from the peritoneal cavity (108 i.p.), MZ splenic immune responses against bacterial-associated anti-
repertoire (M167 clone) joins B1 PC-specific cells (T15 clone) in the
gens, the early wave of plasma cells clearly originatesresponse. When a small dose of antigen (107 i.p.) is injected into the
from B cells with the MZ and B1 phenotype (Figures 2–6).PEC, the response is local, and since the antigen is not systemically
These results support and parallel recent observationsdistributed via the blood, the MZ PC clone is not activated.
When the frequency of MZ PC-specific cells is increased through made in the anti-NP quasimonoclonal mouse model on
cell transfers (B), the response is proportional to the frequency of the kinetics of the early plasmablast response to a TI
PC-specific cells in the MZ and B1 repertoires, respectively. form of hapten (NP-Ficoll (de Vinuesa et al., 1999a,
1999b). Our data provide direct evidence that MZ B cells
respond early to TI antigens and also complement thedisseminate in the blood and initiate a systemic re-
sponse (McDaniel et al., 1984). The PEC response, mea- observations made in pyk-2 gene-targeted mice where
a developmental defect in the production of MZ B cellssured as the number of PC-specific blasts present lo-
cally, is detected only when the antigen is injected i.p. results in a defective immune response to TI antigens
(TNP-Ficoll, FITC-Dextran; Guinamard et al., 2000). Ourirrespective of dose (Figure 6C). At low (107) doses, bac-
teria given i.p. are cleared rapidly and fail to elicit a ability to trace in vivo the activation and compartmental-
ization of T15 PC-responding cells complements andresponse in the spleen, and the local blast production
in the PEC decreases proportionally. adds to our understanding of B1 B cell involvement
in TI responses against phosphorylcholine (Sigal et al.,In order to compare quantitatively the responses of
the M167 and T15 anti-PC clones, the equivalent of 5000 1975; Masmoudi et al., 1990). These results establish a
cellular basis for the ratio of T15 to M167 progenitorM167 Id1 cells from M167 Tg mice were given i.v. before
immunization. In this case, both the M167 MZ-derived levels that exist in the preimmune repertoire and contrib-
ute to the anti-PC response. M167 has been proposed,and the T15 clones were activated after immunization
with high-dose bacteria transferred either i.v. or i.p. (Fig- based on sequence analysis, to be disfavored in the
immunoglobulin gene rearrangement compared to T15ures 6A and 6D). However, low dose i.p. antigen failed
to activate the M167 as well as the T15 cells in the in the fetal liver but not in the adult bone marrow (Feeney,
1991).spleen. The local response was dominated at all times
by the B1 T15 clone, while the M167 MZ clone was not Taking these results together, two questions can be
asked about B cell participation in early TI immune re-significantly recruited and activated in the PEC (Figure
6E). These results suggest that bacteria reaching the sponses. What are the functional differences and simi-
larities between MZ and B1 cells and are their effectorblood (either by direct i.v. or a high dose i.p. injection)
will activate PC-specific clones with either MZ or B1 functions redundant or complementary?
Immunity
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MZ and B1 B Cells—Early Participants 1992; Baumgarth et al., 1999; K. Attanavanich, F.M., and
in Immune Responses J.F.K., unpublished data). It is possible that subsets of
There is extensive evidence that B1 B cells are a major helper cells (T and NK cells) with conserved antigen
source of IgM natural antibodies and also participate in specificities participate with B cells subsets in early
early immune responses as a first line of defense against phases of immune responses. Some evidence for such
many bacteria and viruses (Baumgarth et al., 2000; Och- an orchestrated early immune response is suggested
senbein et al., 1999). Recently, these observations were by properties of CD1-specific NK T cells, certain sub-
extended to include B1 cells as major contributors in populations of gd T cells, and NK cells (Park and Bende-
mucosal IgA responses to commensal bacteria (Mac- lac, 2000; Fagarasan et al., 2000b; Vos et al., 2000).
pherson et al., 2000). The ability of MZ and B1 cells to This constellation of immune responses, together with
differentiate rapidly into effective antibody forming cells their developmental characteristics, incorporates MZ
is reflected at the level of receptor signaling (Bikah et and B1 B cells in the immune system as a type of “natu-
al., 1996; Tanguay et al., 1999; Li et al., 2001). It is of ral” memory B cell: long-lived, with the ability to respond
interest however that anti-IgM signals alone are not able quickly, and with an increased propensity toward termi-
to induce proliferation of MZ and B1 cells. Specifically, nal plasma cell differentiation. Characterization of the
in our experiments it is likely that cosignals, probably exact sequence of signals required for MZ B cells devel-
from mitogens present in bacteria (targeting for example opment will shed also light on their “naivete” for both
the toll-like receptor pathway) as well as from accessory endogenous and environmental stimuli.
cell types (for example macrophage- and dendritic cell-
derived BAFF/BLys), associate with the IgM signal to Redundancy, Backup, or Complementation
induce expansion of antigen-specific cells (MacKay et between MZ and B1 Cells
al., 1999). In addition, analysis of gene-targeted mouse Our observations suggest that there is a programmed
mutants suggests that CD19, btk, and aiolos, as well as topographical segregation of the cellular components
several other molecules that signal immediately down- of the immune system. These specialized B cell subsets,
stream of the sIgM receptor, affect MZ and B1 B cell which respond with different kinetics during specific
compartments similarly. Together, these results suggest immune responses, add a new functional dimension to
that at least some of the pathways involved in the gener- the concept of “geographical immunity” (Zinkernagel et
ation of these two subsets are shared (Wang et al., 1998; al., 1997). The similarities described above between B1
Martin and Kearney, 2000b). Members of the NF-kB and MZ B cells raise the question: why have both sub-
pathway may also be involved in both the development sets? Despite the analogies, there are differences be-
and functions of MZ and B1 cells (Cariappa et al., 2000; tween these B cell subsets that encompass develop-
Fagarasan et al., 2000a). As further evidence, T15-rag ment, topography, phenotype, and function. In addition,
or m knockout mice recruit the T15 clone into the B1 each B cell subset (MZ, B1, and also FO) seems to
compartment and also in the splenic MZ (Kenny et al., exhibit a specialized repertoire generated by alternative
2000; our unpublished data). These data add to the ac- positive selecting mechanisms (Hayakawa et al., 1999;
cumulating evidence for a developmental connection
Martin and Kearney, 2000b). The stringency of the selec-
between MZ and B1 cells that will be clarified once
tion process into the B1 repertoire seems higher than
the sequence of signals involved in their generation are
for MZ B cells and the mechanism different, since many
known.
clones do not join the B1 repertoire although they be-The temporal microevolution of an immune response
come part of the MZ repertoire (Martin and Kearney,is critical when dealing with many pathogenic bacteria
2000b). Conversely, in pyk-2-deficient mice there is aand viruses, which often elicit a strong TI antibody re-
deficiency of MZ B cells and relatively normal B1 B cellsponse early in the course of the infection (Zinkernagel,
generation, suggesting a clear dichotomy with respect1996). Recent work has correlated the extent and char-
to the developmental pathways taken by each subsetacteristics of TI antibody responses to the form and
(Guinamard et al., 2000). This leads us to speculate thatdose of antigen reaching secondary lymphoid organs.
the B1 repertoire has been programmed by evolutionaryThese studies together with the defects occurring after
selection and is particularly efficient in interacting withsplenectomy have firmly established the spleen as the
antigens from the mucosal associated lymphoid tissuemajor lymphoid organ responsible for TI responses un-
environment. The MZ B cells have a more diverse reper-der physiological conditions (Amlot and Hayes, 1985;
toire, molded by past and present antigenic experiencesOchsenbein et al., 2000). Our direct evidence that B cells
of the mouse, and are able to interact with a wider varietywith MZ phenotype participate as a major source of
of potential blood-borne antigens. Also, the ability ofplasmablasts in the same time-frame of the TI immune
MZ B cells to be continuously replenished from the boneresponses explains the role of the spleen in this process.
marrow contrasts with the very limited renewal capacityFuture characterization of cellular trafficking through the
of B1 cells in the adult. As a result, the B1 repertoire ofsplenic MZ will separate the relative contributions of
aged individuals might be exhausted of useful specifici-anatomical location and activation hypersensitivity to
ties and the organism will have to rely more on the MZMZ B cell function.
B cell responses.It is clear that, besides TI early responses, B1 and MZ
Why did most past experiments not pinpoint MZ BB cells with the appropriate specificity can respond to
cells as contributors together with B1 B cells in TI im-TD protein-associated epitopes; however, it is not
mune response? We believe the answer to this questionknown whether this response will also follow an acceler-
is 3-fold. First, most previous analyses of immune re-ated time-course compared to those derived from the
pool of recirculating FO B cells (Linton and Klinman, sponses to TI antigens were done with soluble mole-
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purchased from Jackson Immunoresearch Inc, West Grove, PA.cules (TNP-Ficoll, PC-Ficoll, a1,3-Dextran) that are effi-
The anti-CD21 (7G6) hybridoma was a gift from Dr. Michael Holersciently scavenged by antigen-capturing and processing
(University of Colorado Health Science Center, Denver, CO). PC-cells localized in not only the MZ of the spleen but
Dex-FITC and anti-M167 labeled with PE and biotin were gifts from
also by follicular and other types of dendritic cells and Dr. Jim Kenny (NIH, Washington, DC). AB1-2 (anti-T15 Id) biotin was
macrophages present in tissues other than spleen (Van previously described (Benedict and Kearney, 1999). The anti-CD19
hybridoma (1D6) was obtained from Dr. Douglas Fearon (Universityden Eertwegh et al., 1992). In contrast, as a TI antigen
of Cambridge, England). Anti-Igh6a (RS3.1-FITC and RS3.1-Alexa-we used particulate blood-borne bacteria that are, at
488) and anti-Igh6b (MB.86-FITC) were described (Martin et al.,least within the lymphoid system, scavenged almost
1998). Three- and four-color surface staining and analysis was per-entirely in the splenic MZ by specialized macrophages
formed as previously described (Oliver et al., 1999). Fluoresceinated
(Van den Eertwegh et al., 1993; Buiting et al., 1996). anti-BrdU was purchased from Becton-Dickinson (Mountain View,
Second, intraperitoneal routes of immunization were CA) and used as described (Martin et al., 1998).
Cell sorting for CD21intCD23high and CD21highCD23low B cells wasused in most experiments described previously, in which
done using anti-CD19-PECy5, anti-CD23-FITC, and anti-CD21-PEcase peritoneal B1 cells will likely be the first and only
antibodies as described (Oliver et al., 1997). Cells were sorted withB cells to be exposed and respond to the antigen before
a FACStar Plus (Becton Dickinson, Mountain View, CA) or a MoFloit is cleared. In addition to i.p, we also used i.v. immuni-
(Cytomation, Ft Collins, CO).
zations as a model for blood-borne bacterial encounter
in which many of the bacteria, once scavenged, were Magnetic Cell Sorting
exposed to MZ B cells. Third, although the phenomenon To enrich for PC binding cells in unimmunized mice (Figure 4B),
of clonal enrichment within the B1 compartment was typically 10–20 BALB/c spleens were stained with PC-Dex-FITC and
anti-FITC magnetic beads (Miltenyi Biotec, Auburn, CA) followeddescribed some time ago, a similar restricted profile for
by a double-positive selection on an autoMACS (Miltenyi Biotec,B cells in the MZ was only recently appreciated, thus
Auburn, CA). B220 positive cells from M167 transgenic mice wereproviding homogenous populations of cells that could
obtained with 98%–99% purity using anti-B220 beads (Miltenyi Bio-
be traced in TG mice (Herzenberg, 2000; Martin and tec, Auburn, CA) and double-positive selection.
Kearney, 2000a).
Populations of B cells with low levels of reactivity to Cell Culture
both defined and unknown self-antigens have been also Cells were sorted and plated in 0.2–1 ml of complete RPMI 1640
media at a density of 106/ml in flat wells and cultured alone or withassociated with B1 and MZ B cell repertoires (Hayakawa
LPS (20 mg/ml) for 24 hr. Cells were then isolated, washed, andet al., 1999; Shaw et al., 2000; Martin and Kearney,
used for flow cytometry or RNA extraction.2000a). The facility with which MZ and B1 B cells are
recruited into TI responses is important in the consider-
Immunofluorescence Analysis of Tissue Sectionsation of mechanisms and checkpoints that prevent dis-
Tissue sections were processed and viewed as described (Oliver
ease-inducing autoimmune manifestations of these po- et al., 1999). Frozen sections were stained with MOMA-1 (Rat, Ig-
tentially self-reactive B cells. Reduction of the B cell G2a,k, a gift from Dr. Georg Kraal, specific for mouse splenic metal-
repertoire diversity effectively increases the frequency lophilic macrophages) developed with goat anti-rat IgG-AMCA
(Jackson Immunoresearch Inc, West Grove, PA), blocked with nor-of certain clones and raises the possibility that these
mal rat serum (Peel-Freeze, Rogers, AR), and washed and stained withclones will react as participants or bystanders in TI im-
a mixture of FITC-RS3.1 and PE-M167. When staining for T cells, wemune responses, particularly in the presence of only a
used either anti-CD5 or a mixture of anti-CD4 and anti-CD8 biotin
few high-affinity antigen-specific clones. It is very tempt- developed with SA-AMCA (Vector Laboratories, Burlingame, CA).
ing then to speculate that TI responses can provide
breeding grounds for autoimmune B cell clones resulting Immunizations
from clonal expansion and repeated activation signals 8- to 16-week-old mice were immunized i.v. or i.p. with 108 or 107
heat-killed, pepsin-treated S. pneumoniae (strain R36A, Briles et al.,(Kouskoff et al., 2000). Not only will these clones have
1981). To obtain PC1 and PC2 bacteria, either choline or ethanol-an increased possibility for entry into a pathway leading
amine were included in the growing media. Mice were sacrificedto production of pathogenic autoantibodies but may
and analyzed by FACS and immunofluorescence microscopy.
facilitate transformation events leading ultimately to B
cell neoplasia.
RT-PCR Analysis of Gene Expression
1–2 3 105 B cells (expressing appropriate phenotypes) were directly
Experimental Procedures
sorted into reaction tubes or cultured for a period of time before RNA
extraction. Total RNA was extracted using Tri-Reagent (Molecular
Animals
Research Center, Inc., Cincinnati, OH). Reverse transcriptase poly-
Eight- to twelve-week-old C57BL/6 and BALB/c mice were pur-
merase chain reaction (RT-PCR) was performed on cDNA using
chased from Charles River Laboratories (Raleigh, NC) or bred in our
primers specific for Blimp-1 and actin (Oliver et al., 1997).
mouse facility. mT C57BL/6, T ko (TCRb2/2 TCRd2/2) C57BL/6 mice
were purchased form Jackson Laboratories (Bar Harbor, ME) and
Acknowledgmentsbred with the M167 and 81x transgenic mice. 81x-C57BL/6 (Chen
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